טוען...
Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer
BACKGROUND: Monitoring circulating tumor cells (CTC) has been shown to be prognostic in most solid malignancies. There is no CTC assay in clinical use for lung cancer therapy monitoring due to inconclusive clinical utility data. Limited data has been published outside of the standard CTC enumeration...
שמור ב:
| הוצא לאור ב: | J Transl Med |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6714097/ https://ncbi.nlm.nih.gov/pubmed/31462312 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-019-2035-8 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|